Corbus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.About CRBP
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.
CEOYuval Cohen
CEOYuval Cohen
Employees19
Employees19
HeadquartersNorwood, Massachusetts
HeadquartersNorwood, Massachusetts
Founded2009
Founded2009
Employees19
Employees19
CRBP Key Statistics
Market cap339.24M
Market cap339.24M
Price-Earnings ratio-3.23
Price-Earnings ratio-3.23
Dividend yield—
Dividend yield—
Average volume278.27K
Average volume278.27K
High today$33.77
High today$33.77
Low today$32.33
Low today$32.33
Open price$33.33
Open price$33.33
Volume32.29K
Volume32.29K
52 Week high$49.87
52 Week high$49.87
52 Week low$3.03
52 Week low$3.03
CRBP News
Seeking Alpha 7d
Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology - Seeking Alphasanjeri Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is a biotech stock for investors seeking to gain oncology exposure. Their flagship research project...
